MARC details
000 -LEADER |
fixed length control field |
03809nam a22006498i 4500 |
001 - CONTROL NUMBER |
control field |
BDZ0027302550 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
StDuBDS |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20180923150156.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
160829s2016 nyua f b 001|0|eng|d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780841230293 (hbk.) : |
Terms of availability |
£115.00 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0841230293 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)960906981 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
StDuBDS |
Language of cataloging |
eng |
Transcribing agency |
StDuBDS |
Modifying agency |
StDuBDSZ |
Description conventions |
rda |
050 #0 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
QR186.85 |
Item number |
.S73 2016 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
HEA |
Source |
ukslc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
PSB |
Source |
thema |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MKG |
Source |
thema |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
PNN |
Source |
thema |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
TDCW |
Source |
thema |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Edition number |
616.0798 SCH |
245 00 - TITLE STATEMENT |
Title |
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization. |
Number of part/section of a work |
Volume 2, |
Name of part/section of a work |
Biopharmaceutical characterization / |
Statement of responsibility, etc. |
edited by John E. Schiel, Darryl L. Davis, Oleg V. Borisov. |
246 30 - VARYING FORM OF TITLE |
Title proper/short title |
Biopharmaceutical characterization |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
Oxford University Press, |
Date of publication, distribution, etc. |
2016. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Washington, DC : |
Name of producer, publisher, distributor, manufacturer |
American Chemical Society |
Date of production, publication, distribution, manufacture, or copyright notice |
2104 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
448 pages : |
Other physical details |
illustrations ; |
Dimensions |
23 cm. |
490 1# - SERIES STATEMENT |
Series statement |
ACS symposium series |
490 1# - SERIES STATEMENT |
Series statement |
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization ; |
Volume/sequential designation |
volume 2 |
490 1# - SERIES STATEMENT |
Series statement |
ACS symposium series ; |
Volume/sequential designation |
1201 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
1.Determination of the NIST mAB primary structure. Trina Formolo ... [et al] -- 2.Sequence varianst and sequence variant analysis in biotherapeutic protins. Oleg V. Borisov ... [et al] -- 3.Structural elucidation of post-translational modifications in monoclonal antibodies. Wenzhou Li ... [et al] -- 4.Orthogonal technologies for NIST mAB N-Glycan structure elucidation and quantitation. Justin M. Prien ... [et al] -- 5.Separation methods and orthogonal techniques. David A. Michels ... [et al] -- 6.Biophysical techniques for characterizing the higher order structure and interactions of monoclonal antibodies. Yatin Gokarn ... [et al] -- 7.Developability assessment of a proposed INST monoclonal antibody.Dorina Saro ... [et al] -- 8.Protein particles (0.01 æm, 0.01 æm. Dean C. Ripple and Linda O. Narhi -- 9.Analytical methods for the measurement of host cell proteins and other process-related impurities. Kesh Prakahs and Weibin Chen. |
520 8# - SUMMARY, ETC. |
Summary, etc. |
This volume looks at the characterisation of monoclonal antibodies (mAbs), focusing both on general aspects, techniques and regulatory concerns common to any recombinant protein as well as specific analytical results. It therefore serves as both a foundational body of NISTmAb product knowledge as well as an evaluation of its suitability as an industry-appropriate reference material. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Immunoglobulins |
General subdivision |
Therapeutic use |
9 (RLIN) |
759 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Monoclonal antibodies. |
9 (RLIN) |
758 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical biotechnology. |
9 (RLIN) |
757 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biopharmaceutics. |
9 (RLIN) |
756 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Monoclonal antibodies. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Health and Wellbeing. |
Source of heading or term |
ukslc |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biochemistry |
Source of heading or term |
thema |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology |
Source of heading or term |
thema |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Organic chemistry |
Source of heading or term |
thema |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical chemistry & technology |
Source of heading or term |
thema |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Schiel, John E., |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Davis, Darryl L., |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Borisov, Oleg, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Schiel, John E., |
Relator term |
editor |
9 (RLIN) |
760 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Davis, Darryl L., |
Relator term |
editor |
9 (RLIN) |
761 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Borisov, Oleg, |
Relator term |
editor |
9 (RLIN) |
762 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
American Chemical Society, |
Relator term |
associated with work. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
ACS symposium series ; |
Volume/sequential designation |
1201 |
9 (RLIN) |
764 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization ; |
Volume/sequential designation |
v. 2 |
9 (RLIN) |
763 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Long Loan |
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN) |
h (OCLC) |
NO HOLDINGS IN YQA - 1 OTHER HOLDINGS |